M11 implant (270-0411-06-01-F1)
Ended Awarded Last action
- Contract number
- W81XWH22F0148
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $33,958
Award facts
- Contract value 100% obligated
- $33,958.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $33,958 firm fixed-price call order on May 4, 2022, for M11 implants under a Blanket Purchase Agreement with the Defense Health Agency's Medical Command. The work will be performed in Mounds View, Minnesota, with an ultimate completion date of June 17, 2022. This award represents one of numerous task orders issued against Harvard Bioscience's $4.8 million single-award BPA with the Defense Health Agency, which was established on the same date to support military health system biomedical research requirements through May 3, 2027. No small business set-aside was utilized for this particular call order.
Harvard Bioscience is a self-certified small disadvantaged business specializing in the design and manufacture of advanced physiological monitoring technologies, wireless implantable telemetry transmitters, and related biomedical research instrumentation. The M11 implant is part of the company's comprehensive portfolio of implantable telemetry devices used in preclinical animal research studies. The broader BPA encompasses telemetry acquisition equipment, pre-implanted research animals, hardware and software systems, refurbishment services, and surgical implantation support, with task orders cumulatively exceeding $1.5 million since the agreement's inception. This procurement supports the Defense Health Agency and Army Medical Command's biomedical research operations across multiple military health system facilities.
Quick answers
Who was awarded contract W81XWH22F0148?
W81XWH22F0148 was awarded to Harvard Bioscience Inc. by Medical Command (Department of the Army) on May 4, 2022.
How much is contract W81XWH22F0148 worth?
The government has obligated $33,958 on W81XWH22F0148.
Is contract W81XWH22F0148 an order under another contract?
Yes. W81XWH22F0148 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract W81XWH22F0148 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award